-
-
If a large segment of your patient population is using the monthly contraceptive injection Lunelle, chances are that the last few weeks have been filled with contacting patients, answering questions, and counseling on backup contraception after the manufacturer issued a voluntary recall of prefilled syringes of the product.
-
Add just-published research to your counseling on Depo-Provera (depot medroxyprogesterone acetate or DMPA): Use of the injectable contraceptive is strongly associated with bone density loss; however bone loss appears to be largely reversible once the injections are stopped.1
-
When reviewing birth control options with a teen-age female patient, she tells you that she doesnt want to use the Pill because it will make her gain weight. What do you tell her?
-
In discussing condom use, your college-age male patient tells you that he uses protection on a regular basis. But is he using condoms correctly?
-
As 2002 comes to a close, get ready to add a new lower-dose version of a popular oral contraceptive (OC) to your list of pills, and look to the upcoming 2003 introduction of a generic form of a long-time Pill favorite.
-
This summer, the Bush administration officially announced it was cutting off all U.S. support for the United Nations Population Fund (UNFPA), the largest multilateral population assistance agency in the world.
-
Take a look at your paycheck; chances are if you are in the family planning field, it shows a slight increase from 2001.
-
Progress toward an effective HIV vaccine has encountered a major roadblock with the cessation of a HIV vaccine clinical trial sponsored by Merck & Co. Meanwhile, the need for an effective vaccine continues to grow: The number of new infections in 2006 rose to 4.3 million around the globe, 400,000 more than in 2004.
-
Your patients may be asking you about research news that indicates that use of oral contraceptives (OCs) increase cancer risk for women who use the method for more than eight years.
